Atorvastatin prevents type 2 diabetes mellitus - An experimental study

European Journal of Pharmacology

Volumn 728, Issue 1, 2014, Pages 135-140

  Madhu, Sri Venkata ^a   Aslam, Mohammad ^a   Galav, Vikas ^a   Bhattacharya, Swapan Kumar ^a   Jafri, Aiman Abbas ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Atorvastatin; Glucose area under the curve; Hypertriglyceridemia; Impaired glucose tolerance; Insulin resistance; Type 2 diabetes

Indexed keywords

ATORVASTATIN; GLUCOSE; INSULIN; SUCROSE; CHOLESTEROL; GLUCOSE BLOOD LEVEL; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARBOHYDRATE DIET; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL STUDY; GLUCOSE BLOOD LEVEL; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LONG TERM CARE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANALYSIS; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; LIPID METABOLISM; METABOLISM; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; PYRROLES; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 84896720600     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.01.069     Document Type: Article

References (43)

1. T. Aoki, Y. Yoshinaka, H. Yamazaki, H. Suzuki, T. Tamaki, F. Sato, M. Kitahara, and Y. Saito Triglyceride-lowering effect of pitvastatin in a rat model of postprandial lipaemia Eur. J. Pharmacol. 444 2002 107 113 (Pubitemid 34621340)
2. C.A. Aguilar-Salinas, H. Barrett, and G. Schonfeld Metabolic modes of action of the statins in the hyperlipoproteinemias Atherosclerosis 141 1998 203 207 (Pubitemid 28539628)
3. J.D. Brunzell, M. Davidson, C.D. Furberg, R.B. Goldberg, B.V. Howard, J.H. Stein, J.L. Witztum American Diabetes Association, American College of Cardiology Foundation Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation Diabetes Care 31 2008 811 822
4. S. Bilz, S. Wagner, M. Schmitz, A. Bedynek, U. Keller, and T. Demant Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia J. Lipid Res. 45 2004 174 185 (Pubitemid 38176628)
5. J. Cacho, J. Sevillano, de Castro, E. Herrera, and M.P Ramos Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague Dawley rats Am. J. Physiol. Endocrinol. Metab. 295 2008 E1269 E1276
6. R. Collins, J. Armitage, S. Parish, P. Sleigh, and R. Peto MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
7. J.L. Contreras, C.A. Smyth, G. Bilbao, C.J. Young, J.A. Thompson, and D.E. Eckhoff Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets Transplantation 74 2002 1063 1069 (Pubitemid 35216096)
8. G. Danaei, L.A. García Rodríguez, C.O. Fernandez, and M.A. Hernán Statins and risk of diabetes:an analysis of electronic medical records to evaluate possible bias due to differential survival Diabetes Care 36 2013 1236 1240
9. J.R. Downs, M. Clearfield, S. Weis, E. Whitney, D.R. Shapiro, P.A. Beere, A. Langendorfer, E.A. Stein, W. Kruyer, and A.M. Gotto Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention study JAMA 279 1998 1615 1622 (Pubitemid 28248586)
10. D.T. Furuya, A.C. Poletto, R.R. Favaro, J.O. Martins, T.M. Zorn, and U.F. Machado Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice Metabolism 59 2010 395 399
11. T. Fanatsu, H. Kakuta, T. Takasu, M. Noguchi, M. Suzuki, and K. Miyata Experimental model of post prandial hypertriglyceridemia in sucrose fed rats and the effectiveness of atorvastatin in the model Metabolism 52 2003 609 615 (Pubitemid 36896288)
12. D.J. Freeman, J. Norrie, N. Sattar, R.D. Neely, S.M. Cobbe, I. Ford, C. Isles, A.R. Lorimer, P.W. Macfarlane, J.H. McKillop, C.J. Packard, J. Shepherd, and A. Gaw Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study Circulation 103 2001 357 362 (Pubitemid 32105973)
13. F. Guclu, B. Ozmen, Z. Hekimsoy, and C. Kirmaz Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome Biomed. Pharmacother. 58 2004 614 618 (Pubitemid 40260386)
14. E.M. Horvath, L. Tackett, and J.S. Elmendorf A novel membrane-based anti-diabetic action of atorvastatin Biochem. Biophys. Res. Commun. 372 4 2008 639 643
15. S. Huptas, H.C. Geiss, C. Otto, and K.G. Parhofer Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome Am. J. Cardiol. 98 2006 66 69 (Pubitemid 43902683)
16. W.S. Harris n-3 Fatty acids and serum lipoproteins: animal studies Am. J. Clin. Nutr. 65 1997 1611S 1616S (Pubitemid 27187955)
17. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
18. K.K. Koh, M.J. Quon, S.H. Han, Y. Lee, S.J. Kim, and E.K. Shin Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients J. Am. Coll. Cardiol. 55 2010 1209 1216
19. J. Kjekshus, E. Apetrei, V. Barrios, M. Bohm, J.G. Cleland, J.H. Cornel, P. Dunselman, C. Fonseca, A. Goudev, P. Grande, L. Gullestad, A. Hjalmarson, J. Hradec, A. Jánosi, G. Kamenský, M. Komajda, J. Korewicki, T. Kuusi, F. Mach, V. Mareev, J.J. McMurray, N. Ranjith, M. Schaufelberger, J. Vanhaecke, D.J. Van Veldhuisen, F. Waagstein, H. Wedel, J. Wikstrand Corona Group Rosuvastatin in older patients with systolic heart failure New Engl. J. Med. 357 2007 2248 2261 (Pubitemid 350190755)
20. R. Kamgang, R.Y. Mboumi, G.P. N×dillé, and J.N. Yonkeu Cameroon local diet-induced glucose intolerance and dyslipaemia in adult Wistar rat Diabetes Res. Clin. Pract. 69 2005 224 230 (Pubitemid 41140100)
21. M. Kanda, K. Satoh, and K. Ichihara Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin Biol. Pharm. Bull. 26 2003 1681 1684 (Pubitemid 39663525)
22. A. Keech, D. Colquhoun, J. Best, A. Kirby, R.J. Simes, D. Hunt, W. Hague, E. Beller, M. Arulchelvam, J. Baker, and A. Tonkin Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial Diabetes Care 26 2003 2713 2721 (Pubitemid 37205536)
23. B.R. Krause, and R.S. Newton Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models Atherosclerosis 117 1995 237 244
24. K.C. Marchand, E.J. Arany, and D.J. Hill Effects of atorvastatin on the regeneration of pancreatic β-cells after streptozotocin treatment in the neonatal rodent Am. J. Physiol. Endocrinol. Metab. 299 2010 E92 E100
25. G. Mingrone, F.L. Henriksen, A.V. Greco, L.N. Krogh, E. Capristo, A. Gastaldelli, M. Castagneto, E. Ferrannini, G. Gasbarrini, and H. Beck-Nielsen Triglyceride-induced diabetes associated with familial lipoprotein lapase deficiency Diabetes 48 1999 1258 1263 (Pubitemid 29241023)
26. M. Nakata, S. Nagasaka, I. Kusaka, H. Matsuoka, S. Ishibashi, and T. Yada Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycemic control Diabetologia 49 2006 1881 1892 (Pubitemid 44025043)
27. Y. Nakaya, N. Ishimura, E. Takishita, and A. Takahashi Chronic feeding of nitric oxide synthase inhibitor induces postprandial hypertriglyceridemia in type 2 diabetic model rats, OLETF rats, but not in nondiabetic rats Metabolism 51 2002 702 707 (Pubitemid 34624835)
28. S. Pierno, M.P. Didonna, V. Cippone, A. De Luca, M. Pisoni, A. Frigeri, G.P. Nicchia, M. Svelto, G. Chiesa, C. Sirtori, E. Scanziani, C. Rizzo, D. De Vito, and C.D. Conte Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study Br. J. Pharmacol. 149 2006 909 919 (Pubitemid 44851715)
29. S. Peter, B. Dahlöf, N.R. Poulter, H. Wedel, G. Beevers, M. Caulfield, R. Collins, S.E. Kjeldsen, A. Kristinsson, G.T. McInnes, J. Mehlsen, M. Nieminen, E. O×Brien, J. Ostergren ASCOT investigators Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial Lancet 361 2003 1149 1158 (Pubitemid 36398384)
30. P.M. Ridker, A. Pradhan, J.G. MacFadyen, P. Libby, and R.J. Glynn Cardiovascular benefit and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial Lancet 380 2012 565 571
31. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., J.J. Kastelein for the JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein New Engl. J. Med. 359 2008 2195 2207
32. R.S. Rosensen, C.C. Tangney, and L.C. Casey Inhibition of proinflammatory cytokine production by pravastatin Lancet 353 1999 983 984 (Pubitemid 29132615)
33. N. Sattar, D. Preiss, H.M. Murray, P. Welsh, B.M. Buckley, and A.J. de Craen et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 375 2010 735 742
34. A. Sonmez, Y. Baykal, M. Kilic, M.I. Yilmaz, K. Saglam, F. Bulucu, and I.H. Kocar Fluvastatin improves insulin resistance in nondiabetic dyslipidemic patients Endocrinology 22 2003 151 154
35. J. Spranger, A. Kroke, M. Möhlig, K. Hoffmann, M.M. Bergmann, M. Ristow, H. Boeing, and A.F. Pfeiffer Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study Diabetes 52 2003 812 817 (Pubitemid 36323590)
36. J. Shepherd, G.J. Blauw, M.B. Murphy, E.L. Bollen, B.M. Buckley, S.M. Cobbe, I. Ford, A. Gaw, M. Hyland, J.W. Jukema, A.M. Kamper, P.W. Macfarlane, A.E. Meinders, J. Norrie, C.J. Packard, I.J. Perry, D.J. Stott, B.J. Sweeney, C. Twomey, R.G. Westendorp PROSPER study group Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial Lancet 360 2002 1623 1630 (Pubitemid 35379733)
37. T. Sane, P. Knudsen, H. Vuorinen-Markkola, H. Yki-Järvinen, and M.R. Taskinen Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in non-diabetic subjects with mild hypertriglyceridemia Metabolism 44 1995 589 596
38. T. Sane, and M.R. Taskinen Does familial hypertriglyceridemia predispose to NIDDM? Diabetes Care 16 1993 1494 1501 (Pubitemid 23312538)
39. K.T. Uysal, S.M. Wiesbrock, M.W. Marino, and G.S. Hotamisligil Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function Nature 389 1997 610 614 (Pubitemid 27446179)
40. D.D. Waters, J.E. Ho, D.A. DeMicco, A. Breazna, B.J. Arsenault, and C.C. Wun et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials J. Am. Coll. Cardiol. 57 2011 1535 1545
41. H.J. Wang, Y.X. Jin, W. Shen, J. Neng, T. Wu, Y.J. Li, and Z.W. Fu Low dose streptozotocin (STZ) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression Asia Pacif. J. Clin. Nutr. S16 2007 412 417 (Pubitemid 46524636)
42. 2+ channels in rat islet beta-cells Br. J. Pharmacol. 126 1999 1205 1213 (Pubitemid 29123757)
43. N. Zhang, Y. Huan, H. Huang, G.M. Song, S.J. Sun, and Z.F. Shen Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate Acta Pharmacol. Sin. 31 2010 35 42